66
EVALUATION OF SEVERITY OF AORTIC STENOSIS DR. RAJESH DAS

Evaluation of severity of as

Embed Size (px)

Citation preview

Page 1: Evaluation of severity of as

EVALUATION OF SEVERITY OF AORTIC STENOSIS

DR. RAJESH DAS

Page 2: Evaluation of severity of as

Aortic stenosis- brief Introduction..

Page 3: Evaluation of severity of as

Aortic stenosis: Classification based on location

Valvular- most common type.

Subvalvular.Supravalvular.

Page 4: Evaluation of severity of as

Valvular Aortic Stenosis: Etiology

Most common :-Calcific Aortic Valve Disease

Congenital Bicuspid aortic valve with superimposed calcification.Age related calcific AS of normal trileaflet valve.

Rheumatic AS

Less common:-CongenitalType 2 HyperlipoproteinemiaOchronosis

Page 5: Evaluation of severity of as

Aortic Sclerosis

Irregular thickening of the valve leaflets seen on echo but without significant obstruction.

preserved mobility of the cusps.

Typically associated with peak doppler velocity of less than 2.6 m/sec.

29% of persons > 65 yrs of age exhibited age-related aortic valve sclerosis without stenosis.

Page 6: Evaluation of severity of as

Bicuspid Aortic Valve

The most common congenital cardiac abnormality is bicuspid aortic valve affecting 1-2% of the U.S. population.

Over time, 1/3rd to 1/2 of such valves become stenotic.

significant narrowing of the aortic orifice typically develops in the 5th and 6th decades of life.

Page 7: Evaluation of severity of as

Bicuspid Aortic Valve

Fusion of the right and left coronary cusps (70-80%).

Fusion of the right and non-coronary cusps(20 -30%)

In adults, stenosis in BAV is d/t calcific changes, which often obscures the number of cusps.

Page 8: Evaluation of severity of as

Calcific Aortic Stenosis of trileaflet valve

Nodular calcific masses on aortic side of cusps, most prominent in central part.

No commissural fusion.

Free edges of cusps are not involved.

stellate-shaped systolic orifice.

Valve calcification - predictor of clinical outcome.

Page 9: Evaluation of severity of as

Rheumatic aortic stenosis

Characterized by Commissural fusionTriangular systolic orificethickening & calcification

Accompanied by rheumatic mitral valve changes.

Page 10: Evaluation of severity of as

Subvalvular aortic stenosis

Thin discrete membrane consisting of endocardial fold and fibrous tissue.

A fibromuscular ridge.

Diffuse tunnel-like narrowing of the LVOT.

Accessory or anomalous mitral valve tissue.

Page 11: Evaluation of severity of as

Supravalvular aortic stenosis

Type I – Thick, fibrous ring above the aortic valve with less

mobility and has the easily identifiable 'hourglass' appearance of the aorta.

Type II – Thin, discrete fibrous membrane located above the aortic

valve .The membrane usually mobile and may demonstrate

doming during systole

Type III- Diffuse narrowing.

Page 12: Evaluation of severity of as

Evaluation of severity

• Clinical

• Echocardiographic

• Cardiac Catherization

• Others- CT, MRI etc.

Page 13: Evaluation of severity of as

Clinical evaluation of severity

Page 14: Evaluation of severity of as

Symptoms of severe AS

Cardinal symptoms of AS:Exertional dyspnea and other symptoms of HF.AnginaSyncope

Other complaints: effort intolerance, fatigue. GI or mucosal bleeding.

there is wide individual variability in the severity of outflow obstruction that produces symptoms.

Page 15: Evaluation of severity of as

Signs of severity

Pulsus parvus et tardus (low amplitude, delayed upstroke).Sustained LV impulse.2nd heart sound-

Diminished A2 component.Single d/t absent A2.Paradoxically split S2- in severe AS with LV dysfunction (or in LBBB

d/t LVH)

Prominent S4.Late peaking systolic murmur (though murmur can be absent)

Page 16: Evaluation of severity of as

Echocardiographic assessment of severity

Page 17: Evaluation of severity of as

Doppler assessment of AS

The primary haemodynamic parameters recommended (EAE/ASE Recommendations for Clinical Practice 2009).

Peak transvalvular velocity.

Mean transvalvular gradient.

Valve area by continuity equation.

Page 18: Evaluation of severity of as

Classification of AS severity(based on 2014 AHA/ACC Valvular heart disease guideline)

Page 19: Evaluation of severity of as

Peak transvalvular velocity measurement

CW Doppler ultrasound

Defined as the highest velocity signal obtained from any window after a careful examination.

Multiple acoustic windows Apical, suprasternal or right parasternal most frequently yield the highest velocity.

≥3 are averaged in sinus rhythm, with irregular rhythms at least 5 consecutive beats.

Page 20: Evaluation of severity of as

Peak transvalvular velocity

Deviation from a parallel intercept angle →velocity underestimation

Degree of underestimation is ˂ 5% if the intercept angle is within 15 of parallel.⁰

‘Angle correction’ should not be used.

Page 21: Evaluation of severity of as

Peak transvalvular velocity

to optimize identification of the velocity curve.Wall filters → set at a high levelgain → decreased

A smooth velocity curve with a dense outer edge and clear maximum velocity should be recorded

Page 22: Evaluation of severity of as

Peak transvalvular velocity

The shape of the CW Doppler velocity curve helps distinguishing the level and severity of stenosis.

With severe stenosis, max. velocity occurs later in syst. and the curve is more rounded in shape.

With mild stenosis, the peak is in early syst. with a triangular shape.

Page 23: Evaluation of severity of as

Peak transvalvular velocity

The shape of the CWD velocity curve also helps in determining whether the obstruction is fixed or dynamic.

Dynamic sub aortic obstruction:late- peaking velocity curve, often with a

concave upward curve in early systole

Page 24: Evaluation of severity of as

Mean transvalvular gradient

Gradients are calculated from velocity information

simplified Bernoulli equations: ΔP =4v²

The mean gradient is calculated by averaging the instantaneous gradients over the ejection period.

Page 25: Evaluation of severity of as

Mean transvalvular gradient

The simplified Bernoulli equation assumes that the proximal velocity can be ignored.

When the proximal velocity is over 1.5 m/s or the aortic velocity is <3.0 m/s, the proximal velocity should be included in the Bernoulli equation ΔP max =4 (v² max- v2

proximal)

Page 26: Evaluation of severity of as

Sources of error for pressure gradient calculations

Malalignment of jet and ultrasound beam.Recording of MR jet.

How to differentiate? MR jet is wider (isovolumic periods +E.T.)MR is more symmetrical.In any given pt., MR is faster than AS.MR jet is not recorded in the suprasternal

notch.CW Doppler of AS is superimposed on the

lower velocity of the LVOT.

Page 27: Evaluation of severity of as

Sources of error for pressure gradient calculations

Neglect of an ↑ proximal velocity.

Any underestimation of aortic velocity results in an even greater underestimation in gradients.

Page 28: Evaluation of severity of as

Aortic valve area Continuity equation

Page 29: Evaluation of severity of as

Aortic valve area Continuity equation

Calculation of continuity-equation valve area requires three measurements:

AS jet velocity by CWDLVOT diameter for calculation of a circular CSALVOT velocity recorded with pulsed Doppler.

Page 30: Evaluation of severity of as

Aortic valve area Continuity equation

LVOT diameter and PW of the LVOT needs to taken from the same location in the LVOT.

LVOT diameter → PLAX view

LVOT velocity (or VTI) → apical view – beware of distance error.

The PW sample volume is positioned just prox. to the AV.

Page 31: Evaluation of severity of as

Aortic valve area Continuity equation

LVOT Diameter• LVOT diameter is measured in

the PLAX view in mid-systole from the white–black interface of the septal endocardium to the anterior mitral leaflet, parallel to the aortic valve plane and within 0.5–1.0 cm of the valve orifice.

Page 32: Evaluation of severity of as

Aortic valve area Continuity equation

Velocity or VTI measurement• LVOT velocity is measured from the apical

approach either in an apical long-axis view or an anteriorly angulated four-chamber view

• An optimal signal shows a smooth velocity curve with a narrow velocity range at each time point.

• The VTI is measured by tracing the modal velocity (middle of the dense signal)

Page 33: Evaluation of severity of as

Advantage of the Continuity Equation over Peak velocity Pressure gradient

More reliable in coexisting AR which results in increased stroke volume.

Page 34: Evaluation of severity of as

Pitfalls of the Continuity Equation

Depends on the variability in each of the three measurements (variability in acquiring the data / measuring the recorded data).

When subaortic flow velocities are abnormal e.g. dynamic subaortic obstruction or a subaortic membrane, SV calculations at this site are not accurate.

Page 35: Evaluation of severity of as

Pitfalls of the Continuity Equation

observed changes in valve area with changes in flow rate.

When LV function is normal , the effects of flow rate are minimal and valve area calculations are accurate.

This effect may be significant in concurrent LV dysfunction d/t decreased cusp opening and a small effective orifice area even though severe stenosis is not present.

Page 36: Evaluation of severity of as

Low-flow low-gradient AS

• Effective orifice area ˂1.0 cm2.

• Mean pressure gradient ˂ 30–40 mmHg

Clinical situation where we get Low-flow low-gradient AS are:• AS with LV systolic dysfunction with low LVEF (˂50%):

• Severe AS causing LV syst. dysfunction. • Moderate AS with another cause of LV syst. dysfunction (e.g. MI or a primary

cardiomyopathy).

• AS with small hypertrophied left ventricle with a low stroke volume.• These patients have normal LVEF ( ≥50% ).

Page 37: Evaluation of severity of as

Low Dose Dobutamine Stress Echo

• Measures

• contractile response• changes in aortic velocity, MG, and valve area as flow rate

increases.

• Helps to find out • Severe AS causing LV syst. dysfunction• Moderate AS with another cause of LV dysfunction

Page 38: Evaluation of severity of as

Low Dose Dobutamine Stress Echo- Protocol

• Low dose - 2.5 or 5 µg/kg/min with an incremental increase of 5µg/kg in the infusion every 3–5 min to a maximum dose of 10–20 mg/kg/min.

• The infusion is stopped-• As soon as a positive result is obtained • Heart rate begins to rise more than 10–20 bpm over baseline or

exceeds 100 bpm.• Symptoms, blood pressure fall, or significant arrhythmias.

Page 39: Evaluation of severity of as

Low Dose Dobutamine Stress Echo

RESULTS• AS velocity, MG, valve area, and EF preferably at each stage (to

judge reliability of measurements)

• Severe AS → AS jet ≥ 4.0 m/s or a MG ≥ 40 mmHg provided that valve area does not exceed 1.0 cm2 at any flow rate.

• An increase in valve area to a final valve area of >1.0 cm2 → AS not severe.

Page 40: Evaluation of severity of as

Low Dose Dobutamine Stress Echo

• Absence of contractile reserve (failure to increase SV or EF by 20%)

• predictor of a high surgical mortality• poor long-term outcome.

• If no contractile reserve (no change in SV) and no change in AVA and mean AVG, then we can’t comment on severity of AS

• If doubt remains then TEE may be necessary to assess AV anatomy (3D may be very useful)

Page 41: Evaluation of severity of as

Effects of concurrent conditions on assessment of severity

Page 42: Evaluation of severity of as

Effect of LVH

• LVH commonly accompanies AS• either as a consequence of valve obstruction• or due to chronic hypertension.

• Ventricular hypertrophy typically results in a small ventricular cavity with thick walls and diastolic dysfunction.

• particularly in elderly women with AS.

Page 43: Evaluation of severity of as

Effect of LVH

• The small LV ejects a small SV→• even when severe stenosis is present, the AS velocity and mean gradient may be

lower.

• Continuity-equation valve area is accurate in this situation.

• Many women with small LV size also have a small body size (and LVOT diameter), so indexing valve area to body size may be helpful.

Page 44: Evaluation of severity of as

Effect of Hypertension

• HTN accompanies AS in 35–45% of patients.

• The presence of HTN primarily affect flow and gradients but less AVA measurements.

• Thus, control of BP is recommended before echo evaluation, whenever possible.

Page 45: Evaluation of severity of as

Effect of Aortic Regurgitation

• About 80% of adults with AS also have AR.

• When mild or moderate in severity• measures of AS severity are not significantly affected.

• When severe AR accompanies AS →• transaortic volume flow rate, Vmax, and MG will be higher than expected for a given valve area.

• The combination of moderate AS and moderate AR is consistent with severe combined valve disease.

Page 46: Evaluation of severity of as

Effect of Mitral valve disease

• With severe MR, transaortic flow rate may be low resulting in a low gradient even when severe AS is present.

• Second, a high-velocity MR jet may be mistaken for the AS.

• Mitral stenosis (MS) may result in low cardiac output and, therefore, low-flow low-gradient AS.

Page 47: Evaluation of severity of as

M Mode- Aortic Stenosis

Maximal aortic cusp separation (MACS)Vertical distance between right CC and non CC during systole

DeMaria A N et al. Circulation.Suppl II. 58:232,1978

Page 48: Evaluation of severity of as

Cardiac Catheterization to assess severity

Page 49: Evaluation of severity of as

When to do Cath Study in AS

When noninvasive tests are inconclusive; or

When clinical and echo findings are discrepant.

Page 50: Evaluation of severity of as

Comparing pressure gradients calculated fromdoppler velocities to pressures measured at cardiac catheterization

Page 51: Evaluation of severity of as

Transvalvular gradient Measurement - techniques

Page 52: Evaluation of severity of as

AO & peripheral artery (femoral sheath) showing peripheral amplification of 20 mmHg

Page 53: Evaluation of severity of as

Left ventricular (LV) and right femoral artery (RFA) pressure tracings in a patient who presented with exertional syncope owing to aortic stenosis

demonstrating the significant time delay for the pressure waveform to reach the RFA.

Page 54: Evaluation of severity of as

Carabello Sign…

Page 55: Evaluation of severity of as

Sources of error for pressure gradient calculations

Pressure recovery

Across a narrowed valve there conversion of potential energy to kinetic energy → high velocity and a drop in pressure.

Distal to the orifice, flow decelerates again. Kinetic energy will be reconverted into potential energy with a corresponding increase in pressure, the so-called Pressure Recovery.

Page 56: Evaluation of severity of as

Sources of error for pressure gradient calculations

Pressure recovery

• Doppler derived gradients- using CW doppler @ vena contracta

• Catheter derived gradients- downstream vena contracta- pressure recovery.

Gradient derived by cath is lower than doppler derived gradient

Page 57: Evaluation of severity of as

Sources of error for pressure gradient calculations

Pressure recovery• Stenosis severity

underestimated- “recovered” pressure, rather than vena contracta pressure, is rec

Page 58: Evaluation of severity of as

Sources of error for pressure gradient calculations

Pressure recoveryExaggerated in….

Smaller aortaStiffer aortaHypertension

Aortic stenosis with its abrupt widening from the small orifice to the larger aorta has an unfavorable geometry for PR.

Page 59: Evaluation of severity of as

Aortic Valve area Calculation by cath

Gorlin equation can be used to calculate AVA from pressure gradients, independent of CO.

Hakki formula:

Page 60: Evaluation of severity of as

Low Gradient low flow AS- Cath Study

Dobutamine Stress Test

Page 61: Evaluation of severity of as

Role of CT……..

Page 62: Evaluation of severity of as

Role of CT……..

• The degree of valve calcification measured by MDCT is directly related to valve area.

• Calcium score >1,650 AU indicates of severe AS (sensitivity and specificity ≥ 80%).

• Advantage: • not influenced by hemodynamic conditions, may thus be particularly

useful in the presence of low LV outflow states.• Helpful before TAVR

• Disadvantage: • exposure to ionizing radiation, which limits serial short-time interval

follow-up.• Cost – effectiveness.

Page 63: Evaluation of severity of as

Role of MRI……..

Page 64: Evaluation of severity of as

Role of MRI……..

• Allows direct planimetry of aortic valve orifice at spatial resolution.

• Additionally , can quantify myocardial fibrosis and thus help in prognostication.

But unrealistic due high cost.

Page 65: Evaluation of severity of as

Take Home Message……..

• Transthoracic Echocardiographic evaluation is the mainstay in evaluation of the severity of AS.

• When using Cath study, we should be highly cautious about the technical errors.

Page 66: Evaluation of severity of as

THANK YOU..